ApprovalTrail

Drug · DIN 02291266

TEVA-OXYCODONE CR

No: cancelled before it was sold

Authorized, then cancelled before it was ever sold in Canada.

Status Cancelled Pre Market since October 16, 2015.
Drug Identification Number (DIN)
02291266
Company (DIN owner)
Teva Canada LimitedToronto, Ontario, Canada
Schedule
Narcotics (CDSA I)
Dosage form
Tablet (Extended-Release)
Route
Oral
Therapeutic class (ATC)
Oxycodone N02AA05
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
OXYCODONE HYDROCHLORIDE40 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named TEVA-OXYCODONE CR